IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 48 filers reported holding IBERE PHARMACEUTICALS in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,461,394 | – | 243,944 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Integrity Capital Management (HK) Ltd | 46,717 | $458,000 | 2.36% |
Lynwood Capital Management Inc. | 51,400 | $504,000 | 0.54% |
TEGEAN CAPITAL MANAGEMENT, LLC | 91,422 | $896,000 | 0.48% |
KRYGER CAPITAL Ltd | 422,029 | $4,140,000 | 0.24% |
BASSO CAPITAL MANAGEMENT, L.P. | 170,114 | $1,669,000 | 0.16% |
SPRING CREEK CAPITAL LLC | 400,000 | $3,924,000 | 0.16% |
Vestcor Inc | 400,000 | $3,924,000 | 0.14% |
Castle Creek Arbitrage, LLC | 253,446 | $2,483,000 | 0.12% |
ROBINSON CAPITAL MANAGEMENT, LLC | 17,881 | $175,000 | 0.12% |
Knott David M Jr | 36,000 | $353,000 | 0.11% |